Lewy body dementia trials in South Korea
3 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- Where
- Gangnam-gu, Incheon, Namdong-gu, Seoul
- Age
- 55 years to 85 years
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07589595 - No phaseTaking peopleNatural History Study of Synucleinopathies
- Where
- Seoul
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- NYU Langone Health
See details and how to joinNCT01799915 - Phase 1/2Taking peopleThe Effect of Repetitive Transcranial Magnetic Stimulation on Cognitive Improvement in Dementia With Lewy Bodies
- Where
- Seoul
- Age
- 65 years and over
- People
- 10
- Run by
- Korea University Anam Hospital
See details and how to joinNCT07122908